ClinicalTrials.Veeva

Menu

Evaluating the Durability of Closure for Venous Leg Ulcers (THORSDOTTIR)

K

Kerecis

Status

Enrolling

Conditions

Venous Leg Ulcer
Venous Ulcer
Venous Leg Ulcer (VLU)
Venous Leg
VLU

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT06697925
KS-1020

Details and patient eligibility

About

The goal of this observational study is to determine the durability of closure for venous leg ulcer subjects that achieved closure in the THOR trial.

Full description

To determine durability of closure (rate of target wound recurrence) of subjects with a closed venous leg ulcer during the THOR clinical trial comparing subjects treated with Intact Fish Skin Graft (IFSG) plus standard of care (SOC) to subjects treated with SOC alone.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Subjects must have participated in the THOR trial and achieved complete closure by the 12-week endpoint.

Exclusion criteria

    1. Subjects who did not participate in the THOR trial. 2. Subjects who participated in the THOR trial and did not achieve complete closure.

Trial design

150 participants in 1 patient group

Thor closure patients
Description:
Patients who achieved closure in during the THOR clinical trial

Trial contacts and locations

1

Loading...

Central trial contact

Thomas Serena, MD; Bennett Rogers

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems